New findings presented at ASH indicated that GLP-1 agonists led to a significant reduction in the risk for dangerous blood ...

The new guidance includes updates on diabetes technology use, GLP-1 receptor agonists, liver disease, drinking water, and ...

A Boulder-based company that is developing a orally-delivered drug for obesity and metabolic disorders just reached $25M in ...

The UK Government said existing emergency measures banning the sale and supply of puberty blockers will be made indefinite.

As new research suggests those taking GLP-1 drugs have fewer hospitalisations for alcoholism, a leading specialist warns ...

MASLD is one of the pressing public health issues; yet, unfortunately, there is a scarcity of available pharmacological management options. GLP-1RAs have transformed the treatment landscape for ...

ZURICH, SWITZERLAND / ACCESSWIRE / December 11, 2024 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP)(Nasdaq:NLSPW) ("NLS" or the ...

Eli Lilly has partnered with direct-to-consumer health-care startup Ro to offer more affordable single-dose vials of its ...

The term "nonalcoholic fatty liver disease" (NAFLD) has long been used to describe liver steatosis not related to excessive alcohol consumption ...

PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, ...

Learn how locomotor zone maps are used to study spatial perception and movement patterns, offering insights into behavioral ...

Existing emergency measures banning the sale and supply of puberty-suppressing hormones will be made indefinite, following official advice from ...